Burrows Scott L
5 of 26 shown
The 5 most recent of 26 visible filings, newest first.
- Spyre Therapeutics, Inc. Chief financial officer7,500 sharesOption exercise
- Spyre Therapeutics, Inc. Chief financial officer$21,428Open-market sale
- Spyre Therapeutics, Inc. Chief financial officer$285,449Open-market sale
- Spyre Therapeutics, Inc. Chief financial officer$193,032Open-market sale
- Spyre Therapeutics, Inc. Chief financial officer$135,405Open-market sale